146 related articles for article (PubMed ID: 35851849)
21. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
[TBL] [Abstract][Full Text] [Related]
22. Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands.
Ripping TM; Verbeek AL; Fracheboud J; de Koning HJ; van Ravesteyn NT; Broeders MJ
Int J Cancer; 2015 Aug; 137(4):921-9. PubMed ID: 25612892
[TBL] [Abstract][Full Text] [Related]
23. Effect of three decades of screening mammography on breast-cancer incidence.
Bleyer A; Welch HG
N Engl J Med; 2012 Nov; 367(21):1998-2005. PubMed ID: 23171096
[TBL] [Abstract][Full Text] [Related]
24. Benefit-to-harm ratio of the Danish breast cancer screening programme.
Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
[TBL] [Abstract][Full Text] [Related]
25. Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom.
Gunsoy NB; Garcia-Closas M; Moss SM
Breast Cancer Res; 2012 Nov; 14(6):R152. PubMed ID: 23194032
[TBL] [Abstract][Full Text] [Related]
26. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
27. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.
Yen MF; Tabár L; Vitak B; Smith RA; Chen HH; Duffy SW
Eur J Cancer; 2003 Aug; 39(12):1746-54. PubMed ID: 12888370
[TBL] [Abstract][Full Text] [Related]
28. Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time.
Duffy SW; Parmar D
Breast Cancer Res; 2013 May; 15(3):R41. PubMed ID: 23680223
[TBL] [Abstract][Full Text] [Related]
29. Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort.
Ryser MD; Lange J; Inoue LYT; O'Meara ES; Gard C; Miglioretti DL; Bulliard JL; Brouwer AF; Hwang ES; Etzioni RB
Ann Intern Med; 2022 Apr; 175(4):471-478. PubMed ID: 35226520
[TBL] [Abstract][Full Text] [Related]
30. A case-control study to evaluate the impact of the breast screening programme on mortality in England.
Maroni R; Massat NJ; Parmar D; Dibden A; Cuzick J; Sasieni PD; Duffy SW
Br J Cancer; 2021 Feb; 124(4):736-743. PubMed ID: 33223536
[TBL] [Abstract][Full Text] [Related]
31. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy.
Paci E; Miccinesi G; Puliti D; Baldazzi P; De Lisi V; Falcini F; Cirilli C; Ferretti S; Mangone L; Finarelli AC; Rosso S; Segnan N; Stracci F; Traina A; Tumino R; Zorzi M
Breast Cancer Res; 2006; 8(6):R68. PubMed ID: 17147789
[TBL] [Abstract][Full Text] [Related]
32. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
McCann J; Treasure P; Duffy S
J Med Screen; 2004; 11(3):117-25. PubMed ID: 15333269
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
[TBL] [Abstract][Full Text] [Related]
34. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
Johns LE; Coleman DA; Swerdlow AJ; Moss SM
Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047
[TBL] [Abstract][Full Text] [Related]
35. The influence of breast screening on breast cancer incidence in England: observational study based on cancer registries and bulletins of the NHS Breast Screening Programme.
Autier P; Ould Ammar R; Bota M
Eur J Public Health; 2024 Apr; ():. PubMed ID: 38687973
[TBL] [Abstract][Full Text] [Related]
36. Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden.
Hellquist BN; Duffy SW; Nyström L; Jonsson H
J Med Screen; 2012 Mar; 19(1):14-9. PubMed ID: 22355181
[TBL] [Abstract][Full Text] [Related]
37. Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution.
Duffy SW; Michalopoulos D; Sebuødegård S; Hofvind S
J Med Screen; 2014 Mar; 21(1):24-9. PubMed ID: 24446330
[TBL] [Abstract][Full Text] [Related]
38. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
39. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
